Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg 100-count bottles, Rx Only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Manufactured by: Ascent Pharmaceuticals, Inc. Central Islip, NY 11722, NDC 31722-943-01
Published November 25, 2020 · Recall initiated: October 26, 2020
Summary
FDA records drug Class II recall D-0097-2021, published November 25, 2020 and initiated October 26, 2020. Recalling firm: Ascent Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 9768 Bottles; Lot: Lot #: 20070518, Exp. Date June 2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablet/Capsule: One bottle of Hydrocodone Bitartrate and Acetaminophen Tablets USP 10mg/325 mg contains one Losartan Potassium Tablets, USP 100 mg.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ascent Pharmaceuticals, Inc.
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 20070518, Exp. Date June 2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, Rx only, ManufacturedDecember 15, 2021
- FDASalicylic Acid Shampoo 3%, Bulk Product, 360 TherapeuticsNovember 25, 2020
- FDAHomeopathic Energy Catalyst, 1 fl oz (30 mL) Distributed by: Deseret Biologicals, Inc. 469 W. Parkland DriveNovember 25, 2020
- FDADCL Clear Skin Anti-Blemish Hydrator (2% Salicylic Acid), 50ml/1.7 fl. oz, Dermatologic Cosmetic Laboratories,November 25, 2020
- FDATestosterone Gel 1%, 2.5 grams per unit dose, packaged in 2.5 gram Unit-Dose Packets (NDC 0591-3216-17); 30November 25, 2020
- FDAOxycodone Hydrochloride Tablets, USP 15 mg, 100 count bottles, Rx only, Manufactured for CamberFebruary 7, 2018
Questions about this recall
Was Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg 100-count bottles, Rx Only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Manufactured by: Ascent Pharmaceuticals, Inc. Central Islip, NY 11722, NDC 31722-943-01 recalled?
Yes. FDA published recall D-0097-2021 on November 25, 2020. Reported hazard: Presence of Foreign Tablet/Capsule: One bottle of Hydrocodone Bitartrate and Acetaminophen Tablets USP 10mg/325 mg contains one Losartan Potassium Tablets, USP 100 mg.
What should I do if I have this product?
Voluntary: Firm initiated · Letter